Supplementation of cryomedium with ascorbic acid-2-glucoside (AA2G) improves human sperm post-thaw motility

Fertil Steril. 2011 May;95(6):2001-4. doi: 10.1016/j.fertnstert.2011.02.023. Epub 2011 Mar 16.

Abstract

Objective: To evaluate the efficacy of ascorbic acid-2-glucoside (AA2G) supplementation in cryomedium to improve human sperm motility preservation through the freeze-thaw process.

Design: Prospective research study.

Setting: University-based andrology laboratory.

Patient(s): One hundred thirty-four patients attending the andrology laboratory for a regular semen analysis between April 2009 and May 2010.

Intervention(s): Supplementation of cryomedium with ascorbate or AA2G.

Main outcome measure(s): Endogenous semen ascorbic acid concentrations, semen lipid peroxidation levels, progressive sperm motility.

Result(s): AA2G-supplemented samples showed improved sperm motility preservation after freezing compared with control samples. No significant difference was found in motility preservation between control samples and those supplemented with ascorbate.

Conclusion(s): Our data indicate that AA2G confers a protective effect on human sperm motility preservation through the freeze-thaw cycle. This same effect was not seen with ascorbate. Further investigation is required to elucidate a concrete mechanism of action.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Ascorbic Acid / analogs & derivatives*
  • Ascorbic Acid / metabolism
  • Ascorbic Acid / pharmacology
  • Cryoprotective Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Freezing
  • Humans
  • Lipid Peroxidation / drug effects
  • Male
  • Oxidative Stress / drug effects
  • Semen Analysis
  • Semen Preservation / methods*
  • Sperm Motility / drug effects*
  • Sperm Motility / physiology
  • Spermatozoa / drug effects*
  • Spermatozoa / metabolism

Substances

  • Cryoprotective Agents
  • ascorbic acid 2-O-glucoside
  • Ascorbic Acid